Records containing: Hypertension
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2011-11-08Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)
-
CLINICAL_TRIALS study record update · 2011-11-08A 52-week Extension to the Factorial Study to Evaluate the Efficacy and Safety of VAH631 (Valsartan and Hydrochlorothiazide Combined) and Alone in Essential Hypertensive Patients - Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study) -
-
CLINICAL_TRIALS study record update · 2011-11-08A 52 Week, Open Label Extension to the Randomized, Double-blind, Multicenter, Multifactorial, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients.
-
CLINICAL_TRIALS study record update · 2011-11-08A Study to Describe Vascular and Renal Effects and Safety of Valsartan 80 and 160 mg in Arterial Hypertension Patients
-
CLINICAL_TRIALS study record update · 2011-11-08Dose-finding Study of SPP100 in Essential Hypertension
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2011-11-08Comparison of the Combination of Valsartan 320 mg Plus Hydrochlorothiazide 12.5 mg and Valsartan 320 mg Plus Hydrochlorothiazide 25 mg to Valsartan 320 mg in Mild to Moderate Hypertensive Patients Not Adequately Controlled With Valsartan 320 mg
-
CLINICAL_TRIALS study record update · 2011-11-08Comparative, Open Multicenter Trial Assessing the Effect on Albumin Excretion Rate of 320mg Valsartan (With or Without HCTZ) vs 40mg Lisinopril (With or Without HCTZ) on Hypertensive Patients With Diabetic and Non-diabetic Nephropathy and Albuminuria
-
CLINICAL_TRIALS study record update · 2011-11-08A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension
-
CLINICAL_TRIALS study record update · 2011-11-08A 6-Week Study to Evaluate the Combination of Valsartan/HCTZ (160/12.5mg With Forced Titration to Maximum Dose of 320/25mg) Compared to Valsartan Monotherapy (160mg With Forced Titration to 320mg) as Initial Therapy in Patients With Severe Hypertension
-
CLINICAL_TRIALS study record update · 2011-11-08A Twenty Six-week, Dose Titration Study to Evaluate the Efficacy and Safety of Aliskiren Compared to HCTZ With the Optional Addition of Amlodipine, Followed by a Second Twenty Six Weeks of Blinded Treatment, in Patients With Essential Hypertension
-
CLINICAL_TRIALS study record update · 2011-11-08A 24-week Study to Evaluate the Effectiveness of Valsartan in Combination With Hydrochlorothiazide Versus Amlodipine on Arterial Compliance in Patients With Hypertension, Type 2 Diabetes and Albuminuria
-
CLINICAL_TRIALS study record update · 2011-10-31DEBuT - HET: Device Based Therapy in Hypertension Extension Trial: Long-Term Follow-Up Trial for Patients Who Completed the DEBuT-HT Study
-
CLINICAL_TRIALS study record update · 2011-10-26The Effects of Device-guided Breathing Exercises on Blood Pressure in Patients With Hypertension. A Randomized, Single-blind, Controlled Trial
-
CLINICAL_TRIALS study record update · 2011-10-21Fludrocortisone's Test in the Identification of Salt Sensitivity
-
CLINICAL_TRIALS study record update · 2011-10-20Finding Early Predictors of Myocardial Dysfunction in Patients With Hypertension
-
CLINICAL_TRIALS study record update · 2011-10-20ClinicalTrials.gov study NCT01455974
-
CLINICAL_TRIALS study record update · 2011-10-19A Single Center, Randomized, Double-blind, Active Controlled, Parallel Group Study to Demonstrate Non-inferiority of a Fixed Dose Combination of 5 mg Amlodipine and 80 mg Valsartan to 160 mg Valsartan in the Treatment of Hypertension
-
CLINICAL_TRIALS study record update · 2011-10-13Dietary Interventions for Insulin Resistance and the Metabolic Syndrome
-
CLINICAL_TRIALS study record update · 2011-10-03Molecular - Genetic Alterations in Adipose Tissue After Change in Therapy From ACE Inhibitors to AT1 Receptor Blockers in Patients With Essential Hypertension
-
CLINICAL_TRIALS study record update · 2011-09-29Evaluation of Regional Myocardial Dynamics at Physical Stress in Essential Hypertension
-
CLINICAL_TRIALS study record update · 2011-09-28Renin System Responses to Combined Renin Inhibition and Beta Adrenergic Blockade
-
CLINICAL_TRIALS study record update · 2011-09-27Effects of Angiotensin Converting Enzyme Inhibitors vs Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension
-
CLINICAL_TRIALS study record update · 2011-09-22Central and Peripheral 24h BP and the Association to Autonomic Neuropathy and Diabetic Nephropathy in Type 1 Diabetic Patients
-
CLINICAL_TRIALS study record update · 2011-09-22A Randomized, Double-Blind, Placebo-Controlled, 2-Part Study to Evaluate the Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis in Obese Patients With Hypertension
-
CLINICAL_TRIALS study record update · 2011-09-20Atenolol Exposure as Risk for Adverse Metabolic Responses to Beta Blockers